A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.
Saved in:
| Title: | A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals. |
|---|---|
| Authors: | Vergouwe M; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases., Biemond JJ; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases., van der Straten K; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., van Pul L; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kerster G; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Claireaux M; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Burger JA; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., van Dort KA; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kootstra NA; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Jonges M; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Welkers MRA; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Hazenberg MD; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., Peters-Sengers H; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans., van Gils MJ; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Birnie E; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., de Bree GJ; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands. |
| Corporate Authors: | TURN-COVID study group |
| Source: | The Journal of infectious diseases [J Infect Dis] 2024 Oct 16; Vol. 230 (4), pp. e860-e871. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38843052 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vergouwe+M%22">Vergouwe M</searchLink>; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases.<br /><searchLink fieldCode="AU" term="%22Biemond+JJ%22">Biemond JJ</searchLink>; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases.<br /><searchLink fieldCode="AU" term="%22van+der+Straten+K%22">van der Straten K</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Pul+L%22">van Pul L</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kerster+G%22">Kerster G</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Claireaux+M%22">Claireaux M</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Burger+JA%22">Burger JA</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Dort+KA%22">van Dort KA</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kootstra+NA%22">Kootstra NA</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jonges+M%22">Jonges M</searchLink>; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Welkers+MRA%22">Welkers MRA</searchLink>; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hazenberg+MD%22">Hazenberg MD</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Peters-Sengers+H%22">Peters-Sengers H</searchLink>; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.<br /><searchLink fieldCode="AU" term="%22van+Gils+MJ%22">van Gils MJ</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Wiersinga+WJ%22">Wiersinga WJ</searchLink>; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Birnie+E%22">Birnie E</searchLink>; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Bree+GJ%22">de Bree GJ</searchLink>; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22TURN-COVID+study+group%22">TURN-COVID study group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2024 Oct 16; Vol. 230 (4), pp. e860-e871. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38843052 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiae306 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e860 Titles: – TitleFull: A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vergouwe M – PersonEntity: Name: NameFull: Biemond JJ – PersonEntity: Name: NameFull: van der Straten K – PersonEntity: Name: NameFull: van Pul L – PersonEntity: Name: NameFull: Kerster G – PersonEntity: Name: NameFull: Claireaux M – PersonEntity: Name: NameFull: Burger JA – PersonEntity: Name: NameFull: van Dort KA – PersonEntity: Name: NameFull: Kootstra NA – PersonEntity: Name: NameFull: Jonges M – PersonEntity: Name: NameFull: Welkers MRA – PersonEntity: Name: NameFull: Hazenberg MD – PersonEntity: Name: NameFull: Peters-Sengers H – PersonEntity: Name: NameFull: van Gils MJ – PersonEntity: Name: NameFull: Wiersinga WJ – PersonEntity: Name: NameFull: Birnie E – PersonEntity: Name: NameFull: de Bree GJ IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 10 Text: 2024 Oct 16 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 230 – Type: issue Value: 4 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |
